目的：观察清粘止痛饮治疗插管全麻术后患者呼吸道不适症状的临床疗效。方法：将120 例气管插管全身麻醉术后存在呼吸道不适症状的患者随机均分为常规治疗组和清粘止痛组各60 例。常规治疗组术后予对症支持及预防感染治疗，清粘止痛组在常规治疗组基础上予清粘止痛饮治疗，共治疗2 周。观察并比较术后2 组呼吸道不适症状消失时间、肺部感染治疗总有效率以及不良反应发生情况，并比较术后当天、术后1 周和术后2 周2 组视觉模拟评分法（VAS） 评分、伯格曼舒适度评分（BCS）。结果：治疗后，清粘止痛组患者咳嗽、声嘶、呼吸困难以及吞咽困难等不适症状消失时间均短于常规治疗组（P＜0.05）。与同组术后当天比较，术后1 周、术后2 周2 组VAS 评分均降低（P＜0.05），BCS 评分均升高（P＜0.05）；与常规治疗组术后1 周、术后2 周比较，清粘止痛组术后同一时间VAS 评分较低（P＜0.05），BCS 评分较高（P＜0.05）。常规治疗组肺部感染治疗总有效率75.00%，低于清粘止痛组88.33%，2 组比较，差异无统计学意义（χ2=3.562，P=0.059）。2 组治疗过程中均未发生药物相关不良反应及过敏反应。结论：清粘止痛饮能够有效缓解插管全麻术后导致的咳嗽、声嘶、呼吸困难以及吞咽困难等呼吸道不适症状，并可减少术后肺部感染等并发症，减轻患者痛苦，促进术后恢复，且不增加不良反应。
Abstract：Objective：To observe the clinical effect of Qingnian Zhitong Yin for discomfort symptoms in the respiratory tract of patients after general anesthesia with intubation. Methods：A total of 120 cases of patients who had discomfort symptoms in the respiratory tract after general anesthesia with intubation were randomly divided into the routine treatment group and the Qingnian Zhitong group，with 60 cases in each group. The routine treatment group was given symptomatic support and infection- prevention treatment， and the Qingnian Zhitong group was additionally treated with Qingnian Zhitong Yin based on the treatment of the routine treatment group； both groups were treated for two weeks. The disappearance time of discomfort symptoms in the respiratory tract，the total effective rate of pulmonary infection treatment and the occurrence of adverse reactions were observed and compared in the two groups after operation，and the scores of Visual Analogue Scale(VAS) and Bruggrmann Comfort Scale(BCS) on the day after operation， and one week and two weeks after the operation were compared between the two groups. Results：After treatment， the disappearance time of discomfort symptoms such as cough， hoarseness， dyspnea and dysphagia in the Qingnian Zhitong group was shorter than that in the routine treatment group(P＜0.05). The VAS scores one week and two weeks after the operation in the two groups were decreased when compared with those in the same group on the day after operation(P＜0.05)， and BCS scores were increased(P＜0.05). The VAS scores one week and two weeks after the operation in the Qingnian Zhitong group were lower than those in the routine treatment group at the same time(P＜0.05)， and BCS scores were high(P＜0.05). The total effective rate of pulmonary infection treatment was 75.00% in the routine treatment group， lower than that of 88.33% in the Qingnian Zhitong group， there being no statistically significance in the difference(χ2=3.562，P=0.059). There were no medicine- related adverse reactions and allergic reactions occurred in both groups during the treatment. Conclusion： Qingnian Zhitong Yin has effects in alleviating the discomfort symptoms in the respiratory tract such as cough， hoarseness， dyspnea，and dysphagia caused by anesthesia with intubation，reducing postoperative pulmonary infection and other complications， alleviating patient's pain， and promoting postoperative recovery， without any increase in adverse reactions.